Vantos raises $10.6M for enterprise investigation

Vantos, a Seattle-based software startup with a product that can help companies with internal investigations and auditing, has raised $10.6 in a second round of funding.

Regulatory changes like the passage of Sarbanes-Oxley have opened the way for companies like Vantos. New laws demanding tight controls and tracking of issues can cost public companies millions. While there’s no way to avoid some cost, specialized software can help accountants, lawyers and managers learn how to navigate the… Continue Reading

Life sciences briefing: Wednesday, Jan. 9, 2008

Life sciences briefing: Wednesday, Jan. 9, 2008

TODAY’S HEADLINES:

MRI image-analysis firm Confirma receives $18M (release)
Specialty pharma Zogenix raises $18M (release)
Arcion pulls in $8.8M for topical pain gel (release)
Bayhill Therapeutics files for $87M IPO (Edgar)
Peakdale Molecular, chemistry-services provider, raises £1M (release)
Radiopharmaceutical maker Cellectar draws in $13M (release)
Critical-care drug maker Ikaria names Daniel Tasse as CEO (release)
Noxxon Pharma appoints Frank Morich as CEO (release)

MRI image-analysis firm Confirma receives $18M –Confirma, a Bellevue, Wash., developer of automated systems for medical-image analysis, received $17.5 million in… Continue Reading

Life sciences briefing: Tuesday, Aug. 21, 2007

Life sciences briefing: Tuesday, Aug. 21, 2007

(UPDATED at 7:40pm PT: See below.)

Featured companies: Adnexus Therapeutics, BioForm Medical, Confirma, Cardiovascular Systems, Mirabilis Medica, Neuromed Pharmaceuticals, PlaCor, Seno Medical Instruments, Vibrynt

BioForm Medical files $115M IPO for “medical aesthetics” — BioForm Medical, a San Mateo, Calif., developer of wrinkle fillers and other products for cosmetic procedures, filed to raise $115 million in an initial offering. BioForm’s major customers are plastic surgeons and dermatologists.

BioForm, however, takes pains to describe itself differently on its Web site…. Continue Reading

Life sciences briefing: Thursday, Aug. 16, 2007

Life sciences briefing: Thursday, Aug. 16, 2007

Featured companies: Reliant Technologies, Leptos Biomedical, Calidora Skin Clinic

Reliant Tech seeks $95M IPO for dermatology lasers — Mountain View, Calif.-based Reliant Technologies, a developer of medical lasers for “skin rejuvenation” treatment, filed to raise as much as $95 million in an initial offering. The company currently markets two laser systems for skin treatment under the Fraxel brand name, and intends to launch a third one next year.

Oddly enough, Reliant Tech’s IPO filing comes just days after… Continue Reading